Differential prognostic impact of stratified additional chromosome abnormalities on disease progression among Malaysian chronic myeloid leukemia patients undergoing treatment with imatinib mesylate

The emergence of additional chromosome abnormalities (ACAs) in chronic myeloid leukemia (CML) patients during treatment with a tyrosine kinase inhibitor (TKI) regime is generally associated with resistance to treatment and a sign of disease progression to accelerated phase or blast phase. We report...

Descripción completa

Detalles Bibliográficos
Autores principales: Siti Mariam, Ismail, Norhidayah, Ramli, Zulaikha, Abu Bakar, Nazihah, Mohd Yunus, Rosline, Hassan, Kausar, Ghazali Anis, Sarina, Sulong, Azlan, Husin, Ankathil, Ravindran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393706/
https://www.ncbi.nlm.nih.gov/pubmed/36003793
http://dx.doi.org/10.3389/fonc.2022.720845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393706/
https://www.ncbi.nlm.nih.gov/pubmed/36003793
http://dx.doi.org/10.3389/fonc.2022.720845

Ejemplares similares